Sharp tomosynthesis technology may catch breast cancer earlier

Share this article:

A technology that provides three-dimensional (3D) imaging of the breast may represent the next generation in breast cancer detection.

Similar to computed tomography, tomosynthesis acquires multiple, low-dose images at different angles. The images are then used to produce a series of 1-mm-thick slices that can be viewed as a 3D reconstruction of the breast. Features that might be obscured in a traditional two-dimensional mammogram due to overlapping breast anatomy that may mimic or mask a tumor can be easily identified and characterized in the tomosynthesis-produced images. This can reduce the number of false-positive or false-negative findings.

The tomosynthesis unit resembles earlier mammography machines, and the amount of breast compression required is identical to that required for conventional mammography.

University Hospitals (UH) Case Medical Center (Cleveland, Ohio) was involved with early studies of the tomosynthesis technology, and has announced that its patients are among the first in the nation to be offered the system.

“This revolutionary new technology provides exceptionally sharp images and is an important new tool in our arsenal to detect breast cancer early, when it is treatable,” explained Donna Plecha, MD, director of breast imaging at the medical center, in a statement issued by UH Case Medical Center.

Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Web Exclusives

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Tumor cells prep lymphatic cells to encourage breast cancer cells to spread

Breast cancer cells can lay the groundwork for their own metastasis throughout the body by coaxing cells within lymphatic vessels to send out tumor-welcoming signals.

Protein deletion predicts length of progression free survival (PFS) in patients with ...

Deletion of the Bcl-2-like protein 11 (BIM) in advanced non-small cell lung cancer has been associated with shorter progression free survival (PFS).

Risk of premature menopause after Hodgkin lymphoma treatment is mapped

Women treated for Hodgkin lymphoma will be able to better understand their risks of future infertility after researchers estimated their risk of premature menopause with different treatments.